This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: The University of New Mexico. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Rong Pan: Innovator in Blood Brain Barrier Research
Introduction
Rong Pan is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of medical research, particularly in understanding and treating blood brain barrier (BBB) disruptions. With a total of 4 patents, his work is paving the way for advancements in stroke treatment.
Latest Patents
One of Rong Pan's latest patents focuses on a blood biomarker for early detection of blood brain barrier disruption in ischemic stroke. The methods and apparatus he developed involve detecting the presence of cleaved occludin fragments in a blood sample. This innovative approach allows for determining the degree of BBB damage based on the concentration of these fragments. Additionally, the patent includes the provision of kits designed for detecting occludin fragments in blood samples, enhancing the potential for timely medical intervention.
Career Highlights
Rong Pan is affiliated with Stc.unm, where he continues to engage in groundbreaking research. His work is instrumental in developing methods that could significantly improve patient outcomes following ischemic events. His dedication to innovation in this critical area of healthcare is evident through his patent portfolio.
Collaborations
Rong Pan collaborates with esteemed colleagues, including Ke Jian Liu and Wenlan Liu. Their combined expertise contributes to the advancement of research in the field of blood brain barrier studies.
Conclusion
Rong Pan's contributions to medical research, particularly in the area of blood brain barrier disruption, highlight his role as an influential inventor. His innovative patents and collaborations are set to make a lasting impact on the treatment of ischemic stroke.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
